OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas, Julia María Zuarth-Vázquez, Misael Uribe, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101182-101182
Open Access | Times Cited: 14

Showing 14 citing articles:

Estimated Glucose Disposal Rate predicts the risk of incident Metabolic dysfunction-associated steatotic liver disease
Takahiro Ichikawa, Yoshitaka Hashimoto, Takuro Okamura, et al.
Endocrine Practice (2025)
Closed Access | Times Cited: 1

Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease
Yamei Li, Ping Qi, Siyuan Song, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116585-116585
Open Access | Times Cited: 5

Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease
Weijing Zhang, Wen Jing Song, Weiyu Chen, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 6, pp. 802-810
Open Access | Times Cited: 4

Lean MASLD and Cardiovascular Disease: A Review
Nachum Lebovics, Gabriel Heering, William H. Frishman, et al.
Cardiology in Review (2025)
Closed Access

Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbașa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access

Licochalcone D ameliorates lipid metabolism in hepatocytes by modulating lipogenesis and autophagy
Chian‐Jiun Liou, Shu‐Ju Wu, Hui-Chi Yang, et al.
European Journal of Pharmacology (2024) Vol. 975, pp. 176644-176644
Closed Access | Times Cited: 2

Role of MASLD in CVD: A review of emerging treatment options
Rocco Mollace, Susanna Longo, Matteo Nardin, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111891-111891
Open Access | Times Cited: 1

A new name for an old problem. Metabolic dysfunction-associated steatotic liver disease - review of literature
Adrian Kruszewski, Anna Dąbrowska, Paulina Przybysz, et al.
Quality in Sport (2024) Vol. 17, pp. 53023-53023
Open Access

Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Ana Paula Madariaga Traconis, Misael Uribe, Varenka Julieta Barbero Becerra
Cells (2024) Vol. 13, Iss. 24, pp. 2055-2055
Open Access

Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression
Teng Long, Ling Luo, Yanhong Sun, et al.
Nutrients (2024) Vol. 17, Iss. 1, pp. 152-152
Open Access

Page 1

Scroll to top